EPS Bio Technology Corp. (TPEX:4183)
Taiwan
· Delayed Price · Currency is TWD 20.00
0.00 (0.00%)
May 16, 2025, 10:24 AM CST
EPS Bio Technology Revenue
In the year 2024, EPS Bio Technology had annual revenue of 451.08M TWD, down -4.06%. EPS Bio Technology had revenue of 116.70M in the quarter ending December 31, 2024, a decrease of -22.53%.
Revenue
451.08M
Revenue Growth
-4.06%
P/S Ratio
1.06
Revenue / Employee
4.14M
Employees
109
Market Cap
476.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 451.08M | -19.08M | -4.06% |
| Dec 31, 2023 | 470.17M | 6.72M | 1.45% |
| Dec 31, 2022 | 463.45M | -16.83M | -3.50% |
| Dec 31, 2021 | 480.28M | 2.68M | 0.56% |
| Dec 31, 2020 | 477.60M | 18.25M | 3.97% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Oneness Biotech | 117.33M |
| Pegavision | 6.69B |
| Center Laboratories | 1.63B |